Characteristics of 117 patients at study entry
Median age, y (range) | 49 (27-60) |
| Sex | |
| Male (%) | 89 (76) |
| Female (%) | 28 (24) |
| Hematologic parameters | |
| Median hemoglobin level, g/dL (range) | 13.4 (5.5-16.4) |
| Median white blood cell count, × 109/L (range) | 80 (3-473) |
| Median platelet count, × 109/L (range) | 166 (13-344) |
| Lymphadenopathy, no. of patients | |
| None | 17 |
| Cervical only | 10 |
| Axillary only | 5 |
| Inguinal only | 0 |
| Cervical and axillary | 27 |
| Cervical and inguinal | 3 |
| Axillary and inguinal | 5 |
| Cervical, axillary, and inguinal | 49 |
| Splenomegaly, no. of patients | |
| None | 59 |
| Less than 10 cm | 40 |
| More than 10 cm | 15 |
| Splenectomy | 2 |
| B symptoms, no. of patients | |
| Yes | 77 |
| No | 39 |
| Lymphocytes in bone marrow, no. of patients | |
| Less than 50% | 8 |
| 50%-75% | 19 |
| More than 75% | 64 |
| Bone marrow exam not performed | 26 |
| ECOG performance status, no. of patients | |
| 0 | 98 |
| 1 | 11 |
| 2 | 2 |
| Not specified | 6 |
| Stage of disease, no. of patients (%) | |
| A (progressive) | 27 (23.1) |
| B | 68 (58.1) |
| C | 22 (18.8) |
Median age, y (range) | 49 (27-60) |
| Sex | |
| Male (%) | 89 (76) |
| Female (%) | 28 (24) |
| Hematologic parameters | |
| Median hemoglobin level, g/dL (range) | 13.4 (5.5-16.4) |
| Median white blood cell count, × 109/L (range) | 80 (3-473) |
| Median platelet count, × 109/L (range) | 166 (13-344) |
| Lymphadenopathy, no. of patients | |
| None | 17 |
| Cervical only | 10 |
| Axillary only | 5 |
| Inguinal only | 0 |
| Cervical and axillary | 27 |
| Cervical and inguinal | 3 |
| Axillary and inguinal | 5 |
| Cervical, axillary, and inguinal | 49 |
| Splenomegaly, no. of patients | |
| None | 59 |
| Less than 10 cm | 40 |
| More than 10 cm | 15 |
| Splenectomy | 2 |
| B symptoms, no. of patients | |
| Yes | 77 |
| No | 39 |
| Lymphocytes in bone marrow, no. of patients | |
| Less than 50% | 8 |
| 50%-75% | 19 |
| More than 75% | 64 |
| Bone marrow exam not performed | 26 |
| ECOG performance status, no. of patients | |
| 0 | 98 |
| 1 | 11 |
| 2 | 2 |
| Not specified | 6 |
| Stage of disease, no. of patients (%) | |
| A (progressive) | 27 (23.1) |
| B | 68 (58.1) |
| C | 22 (18.8) |